Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes Pharmaceutical Investing
Health Canada Approves VRAYLAR® for the Treatment of Bipolar l Disorder and Schizophrenia in Adults Pharmaceutical Investing
Pfizer and Biohaven's VYDURA® Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine Life Science Investing
AUPH Stock News: Robbins LLP Investigates Aurinia Pharmaceuticals Inc. on Behalf of Shareholders Pharmaceutical Investing
SHAREHOLDER ALERT: ABBV SDIG LICY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Securities Fraud Class Action Lawsuit Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, RIVN and ABBV Pharmaceutical Investing
AbbVie Inc. Investors: Last Days to Actively Participate in the Class Action Lawsuit; Portnoy Law Firm Pharmaceutical Investing
LAWSUITS FILED AGAINST CRNC, AUPH and LICY - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, SDIG and IRNT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation Pharmaceutical Investing
